Skip to Main Content

Paper Details

Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
J Immunother Cancer
6
2023
Author NameAffiliation
Jamie K TeerH. Lee Moffitt Cancer Center and Research Institute
Jamie K TeerH. Lee Moffitt Cancer Center and Research Institute
  • 1 - 2

Datasets

Release 1.2